Loading...

WuXi Biologics (Cayman) Inc.

WXXWYPNK
Healthcare
Biotechnology
$8.52
$-0.04(-0.47%)
U.S. Market opens in 0h 55m

WuXi Biologics (Cayman) Inc. (WXXWY) Stock Overview

Explore WuXi Biologics (Cayman) Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap17.6B
P/E Ratio24.04
EPS (TTM)$0.34
ROE0.11%
Fundamental Analysis

AI Price Forecasts

1 Month$7.27
3 Months$9.49
1 Year Target$12.80

WXXWY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of WuXi Biologics (Cayman) Inc. (WXXWY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 40.76, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $12.80.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 24.04 and a market capitalization of 17.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.44%
5-Day Change
3.55%
1-Month Change
5.22%
3-Month Change
-10.38%
6-Month Change
-10.48%
Year-to-Date (YTD) Change
6.53%
1-Year Change
44.20%
3-Year Change
-28.42%
5-Year Change
-70.25%
All-Time (Max) Change
-99.89%

Contact Information

+86 510 8183 5000
No. 108, Meiliang Road, Wuxi, NaN, 214092

Company Facts

12,575 Employees
IPO DateDec 18, 2017
CountryCN
Actively Trading

Frequently Asked Questions